Nivasorexant
[4-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone
Molecular Identity
Nivasorexant
[4-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone
PubChem CID: 71566267
2D Structure
Properties
C23H23N7O2
Molecular Formula
429.50
Molecular Weight
g/mol
429.1913
Exact Mass
Da
3.4
XLogP
Drug-like (Lipinski: < 5)
91
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
6
H-Bond Acceptors
625
Complexity
SMILES
Canonical SMILES
SMILES: CC1=CC(=C(C=C1)C(=O)N2CCOCC2CC3=CC(=CC=C3)N4N=CC=N4)N5N=CC=N5Isomeric SMILES
SMILES: CC1=CC(=C(C=C1)C(=O)N2CCOC[C@H]2CC3=CC(=CC=C3)N4N=CC=N4)N5N=CC=N5Synonyms(20)
Nivasorexant1435480-40-20N15II81VXUNII-0N15II81VX[4-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone(4-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)((3R)-3-((3-(2H-1,2,3-triazol-2-yl)phenyl)methyl)-4-morpholinyl)methanone4-(4-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl)-3-((3-(2H-1,2,3-triazol-2-yl)phenyl)methyl)morpholine, (3R)-nivasorexant [INN]Nivasorexant [WHO-DD]orb1687673CHEMBL3892369SCHEMBL14940548SCHEMBL30515244GTPL12719BDBM183990
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Nivasorexant
Loading drug network...